BioCentury
ARTICLE | Company News

AstraZeneca, Zeria deal

August 17, 2015 7:00 AM UTC

Zeria’s Tillotts Pharma AG unit purchased ex-U.S. rights to Entocort budesonide from AstraZeneca for $215 million. Tillotts will assume global supply, distribution, manufacturing, marketing and sales...